These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 29844945)

  • 1. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts.
    Han Y; You X; Xing W; Zhang Z; Zou W
    Bone Res; 2018; 6():16. PubMed ID: 29844945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-Osteoclast Communication and Bone Homeostasis.
    Kim JM; Lin C; Stavre Z; Greenblatt MB; Shim JH
    Cells; 2020 Sep; 9(9):. PubMed ID: 32927921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine and endocrine functions of osteocytes.
    Michigami T
    Clin Pediatr Endocrinol; 2023; 32(1):1-10. PubMed ID: 36761497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones.
    Wang JS; Mazur CM; Wein MN
    Front Endocrinol (Lausanne); 2021; 12():584147. PubMed ID: 33776907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocytes autophagy mediated by mTORC2 activation controls osteoblasts differentiation and osteoclasts activities under mechanical loading.
    Gao L; Liu G; Wu X; Liu C; Wang Y; Ma M; Ma Y; Hao Z
    Arch Biochem Biophys; 2023 Jul; 742():109634. PubMed ID: 37164247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts.
    Sims NA; Vrahnas C
    Arch Biochem Biophys; 2014 Nov; 561():22-8. PubMed ID: 24875146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
    Pathak JL; Bravenboer N; Klein-Nulend J
    Front Endocrinol (Lausanne); 2020; 11():405. PubMed ID: 32733380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
    Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
    PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
    Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
    FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast and osteocyte: games without frontiers.
    Capulli M; Paone R; Rucci N
    Arch Biochem Biophys; 2014 Nov; 561():3-12. PubMed ID: 24832390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor.
    Kubota K; Sakikawa C; Katsumata M; Nakamura T; Wakabayashi K
    J Bone Miner Res; 2002 Feb; 17(2):257-65. PubMed ID: 11811556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Sirtuin 6 in osteoblast lineage cells activates osteoclasts, resulting in osteopenia.
    Kim SJ; Piao Y; Lee MG; Han AR; Kim K; Hwang CJ; Seo JT; Moon SJ
    Bone; 2020 Sep; 138():115497. PubMed ID: 32599221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteocytes.
    Rupp M; Merboth F; Daghma DE; Biehl C; El Khassawna T; Heiß C
    Z Orthop Unfall; 2019 Apr; 157(2):154-163. PubMed ID: 30366349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.